Wednesday, November 15, 2017 11:20:30 AM
Petitioner: Multicell Immunotherapeutics, Inc.
Respondent: GT Biopharma, Inc., and its predecessors Oxis International, Inc. and Oxis Biotech, Inc.
Case Number: 3:2017cv06491
Filed: November 8, 2017
Court: California Northern District Court
Office: San Francisco Office
County: XX US, Outside State
Presiding Judge: Elizabeth D. Laporte
Nature of Suit: Other Statutes: Arbitration
Cause of Action: 09:1 U.S. Arbitration Act
Jury Demanded By: None
https://dockets.justia.com/docket/california/candce/3:2017cv06491/319238
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM